Ramon Bosser possesses more than 25 years’ experience in the pharma and biotech industry, where he has gained extensive R&D, managerial and entrepreneurial skills. Previous to Agomab he was CEO of Origo Biopharma, and had been co-founder and COO at Spherium, a biotech company bringing projects from academia to clinical development in gastrointestinal, dermatology, pain, and nephrology indications. Prior to that he was Director of Program Management at Almirall for more than 10 years, where he headed more than 10 novel drug development projects in respiratory, gastrointestinal, rheumatology, erectile dysfunction and dermatology indications.